Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026)
Green Thumb Industries (GTBIF) posted Capital Expenditures of $18.9 million for Q1 2026, up 28.45% on a QoQ basis from $14.7 million in Q4 2025, and down 36.81% year-over-year from $29.8 million in Q1 2025.
Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026) Analysis & Trends
Green Thumb Industries' Capital Expenditures history runs 8 years deep, the most recent figure standing at $18.9 million for Q1 2026.
- Quarterly Capital Expenditures fell 36.81% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.1 million (down 26.47% YoY) and the FY2025 annual result came in at $81.1 million, up 1.1% from the prior year.
- Capital Expenditures was $18.9 million for Q1 2026 at Green Thumb Industries, up from $14.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $65.0 million in Q1 2023 and bottomed at $14.3 million in Q2 2022.
- A 5-year average of $34.1 million and a median of $27.2 million in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures jumped 350.23% — and 2024, when it plunged 77.37%.
- Green Thumb Industries' Capital Expenditures stood at $59.6 million in 2022, then tumbled by 38.89% to $36.4 million in 2023, then slipped by 25.37% to $27.2 million in 2024, then plunged by 46.02% to $14.7 million in 2025, then gained by 28.45% to $18.9 million in 2026.
- Business Quant data shows GTBIF's Capital Expenditures at $18.9 million in Q1 2026, $14.7 million in Q4 2025, and $17.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 99.60 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 18.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.86 Mn |
| Mar 31, 2026 | 18.86 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Mar 31, 2024 | 14.71 Mn |
| Mar 31, 2024 | 14.71 Mn |
| Dec 31, 2023 | 36.44 Mn |
| Dec 31, 2023 | 36.44 Mn |